On 11 May 2018
Glaxosmithkline Consumer Healthcare will hold a meeting of the Board of Directors of the Company on 11 May 2018, inter alia, to consider and approve, the audited Financial Results of the Bank for the quarter / year ended on March 31, 2018 and to recommend dividend for the year 2017-18, if any.Powered by Capital Market - Live News
Disclaimer: No Business Standard Journalist was involved in creation of this content
